Phase iii trial radiation protective agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Diseases54

Radiation Injuries Lung Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasm Metastasis Breast Neoplasms Neoplasms Disease Progression Adenocarcinoma Neoplasm Recurrence, Local Neutropenia Colorectal Neoplasms Radiation Injuries, Experimental Nausea Carcinoma, Squamous Cell Head and Neck Neoplasms Radiation Pneumonitis Vomiting Pancreatic Neoplasms Neoplasms, Radiation-Induced Carcinoma, Small Cell Ovarian Neoplasms Small Cell Lung Carcinoma Melanoma Brain Neoplasms Prostatic Neoplasms Carcinoma, Renal Cell Stomach Neoplasms Leukopenia Kidney Neoplasms Hand-Foot Syndrome Recurrence Hematologic Diseases Thrombocytopenia Carcinoma Skin Neoplasms Urologic Neoplasms Oligodendroglioma Neoplasms, Glandular and Epithelial Alopecia Bone Neoplasms Radiodermatitis Esophageal Neoplasms Peritoneal Neoplasms Acute Radiation Syndrome Drug-Related Side Effects and Adverse Reactions Carcinoma, Transitional Cell Carcinoma, Large Cell Rectal Neoplasms Urinary Bladder Neoplasms Sarcoma Neoplasms, Second Primary Multiple Myeloma Colonic Neoplasms Anemia

Chemicals and Drugs90

Raffinose Razoxane Antioxidants Glutathione Protective Agents Cisplatin Fluorouracil Deoxycytidine Antineoplastic Agents Paclitaxel Taxoids Vinblastine Carboplatin Antibodies, Monoclonal, Humanized Leucovorin Placebos Doxorubicin Antimetabolites, Antineoplastic Epirubicin Cyclophosphamide Antineoplastic Agents, Phytogenic Platinum Compounds Organoplatinum Compounds Antibodies, Monoclonal Vincristine Etoposide Camptothecin Methotrexate Drugs, Investigational Mitomycin Quinazolines Antineoplastic Agents, Hormonal Prednisone Dacarbazine Megestrol Interferon-alpha Megestrol Acetate Anthracyclines Angiogenesis Inhibitors Quinuclidines Ifosfamide Androgen Antagonists Topotecan Lomustine Antineoplastic Agents, Alkylating Tegafur Antibiotics, Antineoplastic Recombinant Proteins Radiation-Protective Agents Pyrroles Guanine Radiation-Sensitizing Agents Tumor Markers, Biological Pregnadienediols Oxonic Acid Bleomycin Indoles Glutamates Vindesine Drug Combinations Androstenols Triazines Procarbazine Tamoxifen Cancer Vaccines Niacinamide Polyethylene Glycols Phenylurea Compounds Protein Kinase Inhibitors Pyridones Ondansetron Pyrimidines Triazoles Bridged Compounds Granulocyte Colony-Stimulating Factor Thiophenes Benzenesulfonates Diphosphonates Receptor, erbB-2 Nitriles Platinum Thalidomide Mitoxantrone Pyridines Cobalt Radioisotopes Antiemetics Receptor, Epidermal Growth Factor Dexamethasone Uracil Prostate-Specific Antigen

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

Clinical Trials, Phase III as Topic Antineoplastic Combined Chemotherapy Protocols Clinical Trials as Topic Clinical Trials, Phase II as Topic Treatment Outcome Radiation Dosage Disease-Free Survival Drug Administration Schedule Survival Analysis Combined Modality Therapy Dose-Response Relationship, Radiation Chemotherapy, Adjuvant Double-Blind Method Neoplasm Staging Survival Rate Randomized Controlled Trials as Topic Radiation Monitoring Research Design Placebos Kaplan-Meier Estimate Radiotherapy Radiotherapy, Adjuvant Multicenter Studies as Topic Infusions, Intravenous Radiotherapy Dosage Endpoint Determination Prospective Studies Clinical Trials, Phase I as Topic Follow-Up Studies Dose Fractionation Early Termination of Clinical Trials Prognosis Administration, Oral Treatment Failure Neoadjuvant Therapy Maintenance Chemotherapy Proportional Hazards Models Radiation Injuries, Experimental Patient Selection Chemoradiotherapy Remission Induction Cranial Irradiation Sample Size Risk Assessment Risk Factors Drug Therapy, Combination Induction Chemotherapy Palliative Care Radiometry Multivariate Analysis Injections, Subcutaneous Retrospective Studies Chemoradiotherapy, Adjuvant Maximum Tolerated Dose Feasibility Studies Clinical Protocols Immunotherapy Salvage Therapy Karnofsky Performance Status Protective Clothing Drug Approval Molecular Targeted Therapy Drug Evaluation Pilot Projects Statistics, Nonparametric Radiotherapy, Conformal Injections, Intravenous Severity of Illness Index Single-Blind Method Random Allocation Clinical Trials, Phase IV as Topic Orchiectomy Brachytherapy Probability Models, Statistical Radiation Hybrid Mapping Controlled Clinical Trials as Topic Analysis of Variance

Phenomena and Processes19

Oxidative Stress Radiation Dosage Radiation, Ionizing Dose-Response Relationship, Radiation Radiation Tolerance Radiation Time Factors Dose-Response Relationship, Drug Cosmic Radiation Gamma Rays Background Radiation Ultraviolet Rays Maximum Tolerated Dose Radiation Effects Drug Resistance, Neoplasm X-Rays Probability DNA Damage Myoelectric Complex, Migrating

Disciplines and Occupations4

Research Design Radiation Oncology Medical Oncology Radiobiology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life Survival Drug Approval

Technology, Industry, Agriculture2

Protective Clothing Polyethylene Glycols

Humanities1

Quality of Life

Information Science3

Survival Rate Journalism, Medical Radiotherapy, Conformal

Health Care53

Clinical Trials, Phase III as Topic Clinical Trials as Topic Clinical Trials, Phase II as Topic Treatment Outcome Radiation Dosage Disease-Free Survival Radiation Injuries Survival Analysis Dose-Response Relationship, Radiation Double-Blind Method Survival Rate Radiation Protection Randomized Controlled Trials as Topic Radiation Monitoring Kaplan-Meier Estimate Multicenter Studies as Topic Prospective Studies Clinical Trials, Phase I as Topic Follow-Up Studies Early Termination of Clinical Trials Treatment Failure Proportional Hazards Models Radiation Injuries, Experimental Patient Selection Cosmic Radiation International Agencies Sample Size Risk Assessment Risk Factors Ultraviolet Rays Palliative Care Multivariate Analysis Retrospective Studies Feasibility Studies Radiation Effects Clinical Protocols Karnofsky Performance Status Safety Pilot Projects Cost-Benefit Analysis Statistics, Nonparametric Severity of Illness Index Acute Radiation Syndrome Single-Blind Method Random Allocation Clinical Trials, Phase IV as Topic Academies and Institutes Age Factors Probability Radioactive Hazard Release Models, Statistical Controlled Clinical Trials as Topic Analysis of Variance

Geographicals3

Europe United States Japan

Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care Geographicals

Raffinose Clinical Trials, Phase III as Topic Razoxane Antioxidants Glutathione Protective Agents Antineoplastic Combined Chemotherapy Protocols Clinical Trials as Topic Clinical Trials, Phase II as Topic Oxidative Stress Treatment Outcome Radiation Dosage Radiation, Ionizing Disease-Free Survival Cisplatin Radiation Injuries Drug Administration Schedule Fluorouracil Survival Analysis Deoxycytidine Antineoplastic Agents Paclitaxel Combined Modality Therapy Dose-Response Relationship, Radiation Chemotherapy, Adjuvant Double-Blind Method Lung Neoplasms Radiation Tolerance Taxoids Radiation Vinblastine Neoplasm Staging Carboplatin Survival Rate Carcinoma, Non-Small-Cell Lung Radiation Protection Randomized Controlled Trials as Topic Radiation Monitoring Research Design Antibodies, Monoclonal, Humanized Leucovorin Placebos Time Factors Doxorubicin Neoplasm Metastasis Kaplan-Meier Estimate Antimetabolites, Antineoplastic Epirubicin Breast Neoplasms Quality of Life Cyclophosphamide Radiotherapy Radiotherapy, Adjuvant Multicenter Studies as Topic Infusions, Intravenous Radiotherapy Dosage Endpoint Determination Prospective Studies Clinical Trials, Phase I as Topic Follow-Up Studies Antineoplastic Agents, Phytogenic Platinum Compounds Organoplatinum Compounds Dose Fractionation Antibodies, Monoclonal Radiation Oncology Neoplasms Early Termination of Clinical Trials Disease Progression Adenocarcinoma Vincristine Neoplasm Recurrence, Local Etoposide Prognosis Camptothecin Dose-Response Relationship, Drug Methotrexate Neutropenia Drugs, Investigational Administration, Oral Colorectal Neoplasms Treatment Failure Neoadjuvant Therapy Maintenance Chemotherapy Proportional Hazards Models Radiation Injuries, Experimental Mitomycin Nausea Patient Selection Cosmic Radiation Chemoradiotherapy Remission Induction Quinazolines Medical Oncology Carcinoma, Squamous Cell Head and Neck Neoplasms Antineoplastic Agents, Hormonal Prednisone Dacarbazine Radiation Pneumonitis

No FAQ available that match "phase iii trial radiation protective agents"